Stay updated on Dolutegravir for HIV Treatment Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir for HIV Treatment Clinical Trial page.

Latest updates to the Dolutegravir for HIV Treatment Clinical Trial page
- ChecktodayChange DetectedRevision updated from v3.3.3 to v3.3.4; this is a minor metadata/version update with no substantive changes to the page content, study details, locations, or patient information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedAdded a centralized Locations section with regional site listings (Arizona, California, Colorado, Brazil, Canada, Germany, etc.) and removed the prior per-location subsections. Page revision updated to v3.3.3.SummaryDifference2%

- Check51 days agoChange DetectedFooter revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check58 days agoChange DetectedThe funding/operating status notice has been removed from the page, eliminating guidance on processing delays and where to check status.SummaryDifference0.2%

- Check79 days agoChange DetectedBoth screenshots show the same study page with identical title and core content; the changes appear to be only visual styling and layout tweaks. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check101 days agoChange DetectedUpgrade announced: version v3.2.0 replaces v3.1.0 and a government funding-related operating-status notice is added to inform users about potential delays and updated operating details.SummaryDifference4%

Stay in the know with updates to Dolutegravir for HIV Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir for HIV Treatment Clinical Trial page.